[Asia Economy Reporter Minwoo Lee] Bridge Biotherapeutics announced on the 5th that it has signed a technology introduction and joint research agreement for a candidate substance for fundus disease treatment with Konkuk University Industry-Academic Cooperation Foundation.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing